Expanded Access Programs: Ethical and Practical Considerations for Biopharmaceutical Sponsors

Therapeutic Innovation & Regulatory Science
Mitchell KlopfensteinTimothy Garnett

Abstract

Expanded access is a regulatory mechanism by which an investigational drug can be made available outside of a clinical trial to treat patients with serious or life-threatening conditions for which there are no satisfactory treatment options. An expanded access program (EAP) is the formal plan under which preapproval access to an investigational drug can be provided to a group of patients. Although an EAP is a regulated program, the decision to authorize an EAP is the responsibility of the biopharmaceutical sponsor. Because of the significant impact an EAP can have on current patients, drug development, and future patients, we propose that a sponsor's decision must be based not only on regulatory criteria but also on ethical and practical considerations regarding implementation of an EAP. Such an approach will help ensure that decisions and plans uphold ethical precepts such as fairness, promoting good, and minimizing risk of harm.

References

Jun 15, 2006·Bioethics·Sarah J L Edwards
Jan 11, 2007·JAMA : the Journal of the American Medical Association·Peter D Jacobson, Wendy E Parmet
Jun 15, 2007·The American Journal of Bioethics : AJOB·Arthur Caplan
Jul 27, 2007·The New England Journal of Medicine·George J Annas
Oct 11, 2007·The American Journal of Bioethics : AJOB·Shira BenderRosamond Rhodes
Feb 3, 2009·Lancet·Govind PersadEzekiel J Emanuel
Jun 6, 2009·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Elizabeth Weeks Leonard
Feb 5, 2010·Clinical Pharmacology and Therapeutics·J A DiMasiA Wilson
May 15, 2010·Science·Alex John LondonMarina Elena Emborg
Dec 8, 2011·Chest·Leslie P Scheunemann, Douglas B White

❮ Previous
Next ❯

Citations

Mar 27, 2021·BMC Medical Ethics·Luann E Van CampenUNKNOWN Biopharmaceutical Bioethics Working Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Jonathan J DarrowAaron S Kesselheim
Therapeutic Innovation & Regulatory Science
Jonathan P JarowSteven Lemery
The New England Journal of Medicine
Peter LurieJanet Woodcock
© 2022 Meta ULC. All rights reserved